Dr. Gita Dittmar joins Arix Bioscience plc as Venture Partner

Arix Bioscience plc announces Dr. Gita Dittmar as Arix Venture Partner, effective19th April 2021. With over 20 years of experience in the biotechnology sector with direct operating experience in the United States, Europe, and the Middle East, Gita will leverage her global expertise in corporate business development and company building to help Arix grow its existing portfolio companies and support the investment team by identifying and evaluating new investment opportunities through her established networks.

Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company holds interests in BioMotiv, OptiKira LLC, Autolus, Depixus SAS, Verona Pharma plc and Artios Pharma Ltd. The Company has agreements with universities in the United Kingdom, Europe and Australia, providing direct access to new technologies. It also has access to a range of research projects from the United States academic institutions. Its subsidiaries include Arix Bioscience Holdings Limited, Arix US Inc and Arthurian Life Sciences GP Limited.